Effect of Bright Light Therapy on Depression Symptoms in Adult Inpatients With Cystic Fibrosis (CF) and Chronic Obstructive Pulmonary Disease (COPD)
Trial Snapshot
- Phase
- Not Applicable
- Status
- Terminated
- Sponsor
- Enrollment
- 4
- Locations
- 2
- Primary Endpoint
- Change in Pre- and Post-intervention Beck's Depression Inventory II Scores (BDI-II)
Study Overview
Brief Summary
This is a project that will determine whether the use of daily bright light therapy has an effect on depressive symptoms experienced by adult inpatients with CF and COPD. The purpose of this project is to apply a daily 30-minute BLT intervention to hospitalized adult CF and COPD patients in order to decrease symptoms of depression as measured by depression inventory scoring.
Detailed Description
This project will occur on a 29-bed pulmonary step-down unit at a 1,600-bed academic medical center. This unit commonly treats patients with CF, COPD, and other pulmonary complications. The unit's patient care staff will be educated on the bright light lamps in order to prevent interruptions and to encourage compliance.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Supportive Care
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Diagnosed with cystic fibrosis or chronic obstructive pulmonary disease (COPD)
- •Adult age 18 or older
- •Admitted to the pulmonary step-down and transplant unit
- •Score greater than zero on pre-intervention Beck's Depression Inventory-II (BDI-II)
Exclusion Criteria
- •Pre-existing ophthalmological conditions or photosensitivity
- •Migraines
- •Receiving high dose steroids for transplant rejection (due to mood altering qualities),
- •Antibiotics that increase light sensitivity
- •Diagnosed with bipolar disorder (light therapy may trigger mania)
- •Admissions anticipated to span less than 48 hours
- •Children are being excluded due to the fact that only adult CF and COPD subjects are admitted to University of Pittsburgh Medical Center (UPMC) Presbyterian hospital
Arms & Interventions
Bright Light Therapy (BLT)
The intervention will consist of daily BLT sessions lasting 30 minutes at approximately 10AM (since many CF and COPD patients may not awaken until this time) starting on the day of admission through discharge for a goal of seven consecutive days. The intervention will use a 10,000-lux light box placed approximately 16-24 inches from the patient's face.
Intervention: Bright Light Therapy (BLT) Lamp (Device)
Outcomes
Primary Outcomes
Change in Pre- and Post-intervention Beck's Depression Inventory II Scores (BDI-II)
Time Frame: First at time of admission, second at end of 7 day goal or upon discharge.
Change between pre-intervention and post-intervention self-reported answer totals to the 21 scored items on BDI-II (minimum score obtainable=0 (absent symptoms); maximum score obtainable=63 (most severe symptoms).
Secondary Outcomes
- Number of Days Until Completion of Daily Bright Light Therapy (BLT)(Daily for duration of intervention period (goal/maximum of 7 days).)
Investigators
Erica Osborn
Principal Investigator
University of Pittsburgh